ONYX Pharmaceuticals ROCKETS 43% to Lead These 4 NASDAQ Top Percentage Winners

ONYX Pharmaceuticals, Inc. (NASDAQ:ONXX) had its price target raised by BMO Capital following word that an FDA panel recommended approval of the company’s carfilzomib for patients with relapsed and refractory multiple myeloma. Moreover, BMO predicts that the drug will be okayed and launched before the end of 2012, and keeps an Outperform rating on the shares, which closed up a whopping 43.07 percent Thursday at $63.78. The had traded between $27.17 and $47.80 in the last 52 weeks.

Don’t Miss: HEALTHY Drug Stocks Offering a Prescription for Stock Market PAIN.

Sun Healthcare Group, Inc. (NASDAQ:SUNH), which is the largest tenant of Sabra Health Care REIT (NASDAQ:SBRA) announced Wednesday that it has signed a definitive agreement to be purchased by Genesis Healthcare. Shares closed up a huge 36.81 percent Thursday at $8.40, having traded between $2.06 and $8.77 in the last 52 weeks.

Eagle Bulk Shipping Inc. (NASDAQ:EGLE) shares are currently up 45.1 percent on heavy volume, subsequent to the news that the firm worked out an arrangement with lenders that steers around defaults. Even so, the shares remain more than 50 percent below their 2012 high of $9, which is in a 52-week range of $2.51 to $11.00. They closed up 31.21 percent Thursday at $3.91.

Celsion Corporation (NASDAQ:CLSN) shares closed up 9.66 percent at $2.61, and have traded in a 52-week range of between $1.63 and $4.37.

Don’t Miss: Healthcare Biz Recap: Onyx Receives FDA APPROVAL, Novartis STICKS with Russia.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.